Berlex names new CEO
Executive Summary
Reinhard Franzen becomes Berlex president and CEO effective April 1. Franzen has served as COO since Jan. 1 after holding the position of VP and general manager of Berlex' women's health business. Franzen replaces Dale Stringfellow, PhD, who will remain as chairman of Collateral Therapeutics, which Berlex recently acquired...
You may also be interested in...
Q&A: Renalytix AI Prez Explains How MCIT Rule Will Aid Kidney Product Coverage By CMS
Tom McLain tells how the new MCIT policy from the US Medicare agency – and winning support from Congress – will guarantee Medicare coverage for his company’s product, an artificial intelligence-enabled in vitro diagnostic platform.
Bridges Consumer Startup Reaches Brands For Specialty Conditions In Clarion Deal
Acquiring Clarion Brands from Swander Pace, Bridges Consumer Healthcare adds portfolio of OTC and supplement brands for symptoms including tinnitus, urinary pain relief and excessive sweating.
MDIC Proposes Real-World Evidence Framework For Sponsors To Hasten Their Product Application
The document from the Medical Device Innovation Consortium aggregates external data sources, various statistical methods and lays out other considerations for sponsors to help speed up and bolster a premarket product application to the US FDA.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: